$LBUY
LEAFBUYER TECHNOLOGIES, INC.

2024 Q1 Form 10-Q Financial Statement

#000147793224000728 Filed on February 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2022 Q4
Revenue $1.497M $1.434M $1.342M
YoY Change 16.37% 6.89% 45.24%
Cost Of Revenue $933.7K $985.5K $625.6K
YoY Change 21.3% 57.52% -5.51%
Gross Profit $563.1K $448.7K $718.1K
YoY Change 9.03% -37.52% 174.34%
Gross Profit Margin 37.62% 31.28% 53.52%
Selling, General & Admin $398.1K $356.1K $324.5K
YoY Change 19.8% 9.75% -10.11%
% of Gross Profit 70.7% 79.37% 45.18%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $181.1K $182.2K $181.1K
YoY Change 0.0% 0.61% 0.0%
% of Gross Profit 32.17% 40.61% 25.22%
Operating Expenses $702.5K $645.7K $579.1K
YoY Change 7.82% 11.51% -22.86%
Operating Profit -$139.4K -$197.1K $136.2K
YoY Change 3.21% -244.73% -127.85%
Interest Expense $32.22K $22.94K $44.11K
YoY Change -9.02% -47.98% -104.98%
% of Operating Profit 32.39%
Other Income/Expense, Net $0.00 $10.00 $3.380K
YoY Change -100.0% -99.7%
Pretax Income -$171.7K -$220.0K -$245.9K
YoY Change 0.7% -10.51% -82.1%
Income Tax
% Of Pretax Income
Net Earnings -$171.6K -$220.0K $95.40K
YoY Change 0.7% -330.63% -106.94%
Net Earnings / Revenue -11.47% -15.34% 7.11%
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 99.43M shares 99.43M shares 94.85M shares
Diluted Shares Outstanding 145.7M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $155.9K $226.7K $298.2K
YoY Change -64.15% -23.99% -34.05%
Cash & Equivalents $155.9K $226.7K $298.2K
Short-Term Investments
Other Short-Term Assets $21.00K $16.60K $24.38K
YoY Change -23.3% -31.91% 33.01%
Inventory
Prepaid Expenses
Receivables $194.4K $145.1K $58.66K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $371.4K $388.4K $381.3K
YoY Change -29.58% 1.85% -27.48%
LONG-TERM ASSETS
Property, Plant & Equipment $1.500K $1.500K $1.587M
YoY Change -99.89% -99.91% -31.34%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00
YoY Change
Total Long-Term Assets $681.7K $862.8K $1.587M
YoY Change -51.52% -45.64% -31.34%
TOTAL ASSETS
Total Short-Term Assets $371.4K $388.4K $381.3K
Total Long-Term Assets $681.7K $862.8K $1.587M
Total Assets $1.053M $1.251M $1.969M
YoY Change -45.54% -36.44% -30.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $227.8K $341.4K $198.8K
YoY Change -19.83% 71.75% -41.51%
Accrued Expenses $1.075M $1.093M $939.5K
YoY Change -4.67% 16.29% -6.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.067M $1.077M $1.584M
YoY Change -28.06% -32.04% -8.42%
Total Short-Term Liabilities $2.383M $2.512M $2.730M
YoY Change -17.84% -7.96% -13.14%
LONG-TERM LIABILITIES
Long-Term Debt $456.1K $463.4K $500.0K
YoY Change -6.02% -7.31% 0.0%
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $456.1K $463.4K $500.0K
YoY Change -6.02% -7.31% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.383M $2.512M $2.730M
Total Long-Term Liabilities $456.1K $463.4K $500.0K
Total Liabilities $2.839M $2.976M $3.230M
YoY Change -16.14% -7.86% -11.34%
SHAREHOLDERS EQUITY
Retained Earnings -$25.23M -$25.05M -$23.97M
YoY Change 3.95% 4.55% 3.2%
Common Stock $100.1K $99.43K $98.77K
YoY Change 4.86% 0.66% 7.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.786M -$1.725M -$1.261M
YoY Change
Total Liabilities & Shareholders Equity $1.053M $1.251M $1.969M
YoY Change -45.54% -36.44% -30.62%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2022 Q4
OPERATING ACTIVITIES
Net Income -$171.6K -$220.0K $95.40K
YoY Change 0.7% -330.63% -106.94%
Depreciation, Depletion And Amortization $181.1K $182.2K $181.1K
YoY Change 0.0% 0.61% 0.0%
Cash From Operating Activities -$53.43K $60.58K $110.2K
YoY Change -121.13% -45.04% -195.11%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -17.31K -29.62K -37.31K
YoY Change -85.1% -20.61%
NET CHANGE
Cash From Operating Activities -53.43K 60.58K 110.2K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities -17.31K -29.62K -37.31K
Net Change In Cash -70.74K 30.96K 72.92K
YoY Change -151.76% -57.54% -162.92%
FREE CASH FLOW
Cash From Operating Activities -$53.43K $60.58K $110.2K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
dei Entity Central Index Key
EntityCentralIndexKey
0001643721
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
99428575 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
99428575 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
lbuy Dividend Yield Percent
DividendYieldPercent
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0.00
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-206745
dei Entity Registrant Name
EntityRegistrantName
LEAFBUYER TECHNOLOGIES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
38-3944821
dei Entity Address Address Line1
EntityAddressAddressLine1
6888 S. Clinton Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 300
dei Entity Address City Or Town
EntityAddressCityOrTown
Greenwood Village
dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80112
dei City Area Code
CityAreaCode
720
dei Local Phone Number
LocalPhoneNumber
235-0099
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
99428575 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
99428575 shares
CY2023Q4 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
0 usd
CY2022Q4 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
0 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
0 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
0 usd
CY2023Q4 lbuy Forgiveness Of Loan
ForgivenessOfLoan
0 usd
CY2022Q4 lbuy Forgiveness Of Loan
ForgivenessOfLoan
0 usd
lbuy Forgiveness Of Loan
ForgivenessOfLoan
0 usd
lbuy Forgiveness Of Loan
ForgivenessOfLoan
0 usd
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145749028 shares
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1412547 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
187132 usd
lbuy Stock Issued During Period Value Issued For Vendor Payments
StockIssuedDuringPeriodValueIssuedForVendorPayments
28500 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
50454 usd
us-gaap Net Income Loss
NetIncomeLoss
-114576 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1261040 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-1278871 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
172973 usd
us-gaap Net Income Loss
NetIncomeLoss
-618608 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1724506 usd
us-gaap Profit Loss
ProfitLoss
-618608 usd
us-gaap Profit Loss
ProfitLoss
-114576 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
172973 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
237587 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
28500 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
0 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
0 usd
lbuy Forgiveness Of Ppp Loans
ForgivenessOfPppLoans
0 usd
lbuy Forgiveness Of Ppp Loans
ForgivenessOfPppLoans
0 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
362223 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
362223 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-9595 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-29573 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
12668 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1274 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
32565 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-162151 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-81644 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-244094 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-129418 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
76642 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
89622 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
145644 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-89622 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-145644 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-219040 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-69002 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
445721 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
367245 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
226681 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
298243 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
lbuy Issuance Of Common Stock For Vendor Payments
IssuanceOfCommonStockForVendorPayments
0 usd
lbuy Issuance Of Common Stock For Vendor Payments
IssuanceOfCommonStockForVendorPayments
28500 usd
us-gaap Net Income Loss
NetIncomeLoss
-618608 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Certain prior period amounts have been reclassified to conform with the current period presentation.</p>
CY2019 lbuy Amortization Of Beneficial Conversion Feature
AmortizationOfBeneficialConversionFeature
801741 usd
CY2019 us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
533000 usd
CY2019 us-gaap Repayments Of Debt
RepaymentsOfDebt
402000 usd
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
131000 usd
CY2019 lbuy Remaining Principal Amount
RemainingPrincipalAmount
90125 usd
CY2023Q4 lbuy Unpaid Principal Including Interest Amount
UnpaidPrincipalIncludingInterestAmount
385913 usd

Files In Submission

Name View Source Status
0001477932-24-000728-index-headers.html Edgar Link pending
0001477932-24-000728-index.html Edgar Link pending
0001477932-24-000728.txt Edgar Link pending
0001477932-24-000728-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lbuy-20231231.xsd Edgar Link pending
lbuy_10q.htm Edgar Link pending
lbuy_ex311.htm Edgar Link pending
lbuy_ex312.htm Edgar Link pending
lbuy_ex321.htm Edgar Link pending
lbuy_ex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lbuy-20231231_lab.xml Edgar Link unprocessable
lbuy-20231231_pre.xml Edgar Link unprocessable
lbuy_10q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
lbuy-20231231_cal.xml Edgar Link unprocessable
lbuy-20231231_def.xml Edgar Link unprocessable